Veteran investment executive with multi-decade experience across private equity, corporate finance and asset management, focused on value creation and operational improvement. Scott D. Lasky combines operating leadership, portfolio management and board service supporting growth-stage and middle-market companies across technology, healthcare and consumer sectors. Regularly engaged in deal sourcing, M&A execution, capital formation and investor relations, he is positioned as a strategic sponsor for buyouts, growth equity and turnaround situations.
Veteran investment executive with multi-decade experience across private equity, corporate finance and asset management, focused on value creation and operational improvement. Scott D. Lasky combines operating leadership, portfolio management and board service supporting growth-stage and middle-market companies across technology, healthcare and consumer sectors. Regularly engaged in deal sourcing, M&A execution, capital formation and investor relations, he is positioned as a strategic sponsor for buyouts, growth equity and turnaround situations.
Combines operational leadership and private-capital discipline to target value-accretive opportunities in growth-stage and middle-market companies. Prefers control or significant influence positions where active board engagement and hands-on operational improvement drive EBITDA expansion and strategic M&A. Uses a flexible capital approach—buyouts, growth equity and restructurings—with focus on technology, healthcare and consumer verticals. Investment horizon is medium to long-term, emphasizing rigorous due diligence, conservative leverage, staged capital deployment and exit-ready value creation plans aligned with management and limited partners.
Combines operational leadership and private-capital discipline to target value-accretive opportunities in growth-stage and middle-market companies. Prefers control or significant influence positions where active board engagement and hands-on operational improvement drive EBITDA expansion and strategic M&A. Uses a flexible capital approach—buyouts, growth equity and restructurings—with focus on technology, healthcare and consumer verticals. Investment horizon is medium to long-term, emphasizing rigorous due diligence, conservative leverage, staged capital deployment and exit-ready value creation plans aligned with management and limited partners.
| Trades 645 | Longs Won 394/645 61% | Profit Factor 5.25 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $192,472.71 |
| Average Win $81,438.67 | Best Trade (Oct 14) $2.23M | Sharpe Ratio -12.8 |
| Average Loss -$24,355 | Worst Trade (Mar 31) -$452,586.22 | Z-Score 3.72 (99.98%) |
| Commissions $0 | Avg. Trade Length 10m 1w 4d | Expectancy $40,269.35 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 6,369 | 5,732 | 5,096 | 4,459 | 3,822 | 3,185 | 2,548 | 1,911 | 1,274 | 637 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 25,169 | $6.35M | $8.62M | - | $2.27M | 35.82% | -0.096% |
ABBV AbbVie Inc. | 4,720 | $1.05M | $1.34M | - | $289,245.58 | 27.49% | +0.268% |
ABT Abbott Laboratories | 2,221 | $300,034.31 | $232,783.01 | - | -$67,251.3 | -22.41% | +1.787% |
AGGY WisdomTree Yield Enhanced U.S. Aggregate Bond Fund | 10,753 | $467,345.76 | $448,668.92 | - | -$18,676.84 | -4% | +0.688% |
AMD Advanced Micro Devices, Inc. | 5,120 | $767,482.08 | $2.9M | - | $2.13M | 277.51% | -0.865% |
AMZN Amazon.com Inc | 5,951 | $1.31M | $1.52M | - | $213,116.83 | 16.32% | +0.443% |
AOS A. O. Smith Corporation | 18,976 | $1.27M | $1.12M | - | -$151,144.09 | -11.87% | +2.213% |
ASTS AST SpaceMobile, Inc. | 5,000 | $233,650 | $224,500 | - | -$9,150 | -3.92% | +6.55% |
AVDS Avantis International Small Cap Equity ETF | 2,984 | $185,624.25 | $229,917.2 | - | $44,292.95 | 23.86% | +0.186% |
AVGO Broadcom Inc. | 652 | $246,293 | $224,627.04 | - | -$21,665.96 | -8.8% | -0.5% |
AXP American Express Company | 606 | $204,980 | $190,387.02 | - | -$14,592.98 | -7.12% | +2.352% |
AZZ Azz Inc. | 14,000 | $1.45M | $1.83M | - | $377,650 | 26.06% | -5.201% |
B BARRICK MINING CORP Common Stock (ABR0) | 6,388 | $209,335 | $259,065.34 | - | $49,730.34 | 23.76% | +4.281% |
BA Boeing Company | 1,443 | $312,366 | $271,529.31 | - | -$40,836.69 | -13.07% | +1.901% |
BAB Invesco Taxable Municipal Bond ETF | 10,210 | $268,916.84 | $262,652.25 | - | -$6,264.59 | -2.33% | +0.764% |
BAC Bank of America Corporation | 4,821 | $249,216.54 | $249,197.49 | - | -$19.05 | -0.01% | +0.584% |
BIV Vanguard Intermediate-Term Bond ETF (likely mapping for ticker 0V1L) | 75,759 | $5.7M | $5.57M | - | -$131,176.39 | -2.3% | +0.623% |
BNY BlackRock New York Municipal Income Trust | 7,339 | $566,669.26 | $1.04M | - | $475,432.04 | 83.9% | +3.16% |
BOND PIMCO Active Bond Exchange-Traded Fund | 8,920 | $813,388.28 | $783,800.4 | - | -$29,587.88 | -3.64% | +0.676% |
BRK-B Berkshire Hathaway Inc. | 1,704 | $776,344.82 | $897,437.13 | - | $121,092.31 | 15.6% | +0.06% |